with a in UC patients, annual cost of measure of addition on the 27 (19.3%) treating 5,440 effectiveness to a study did not patients was sample present. $198,016 with TD The was Further and $116,416 effectiveness request, not details on with UC. Thus, evidence came system. and then the study the average cost from a clinical evaluated design were per patient was trial, which whether not $21.40 for UC was to and $36.40 for appropriate schedule 2002) TD. for the study the question. patient -The analysis However, the for a of the study had The incremental clinical study been cost per patient used actual published was $15. clinic visit already and or to data. These limited relay a data were information diagnosis derived from on the and The sensitivity clinic visit methods, treatment analysis showed occurrences study sample plan back that the and and results to the incremental cost accounted was provided. referring per patient did for no-show The use of a clinician. not vary rates or randomised substantially in trial ensures a the alternative with clinic high internal scenarios (the visit validity. incremental cost However, it varied from was not $10.50 to $13.85).
with a system. in addition to a request, and then evaluated whether to schedule the patient for a or to relay a diagnosis and treatment plan back to the referring clinician. on the study sample was not UC patients, 27 (19.3%) did not present. Further details on the study design were not 2002) -The analysis of the clinical study used actual clinic visit data. These data were derived from clinic visit occurrences and accounted for no-show rates or with clinic visit annual cost of treating 5,440 patients was $198,016 with TD and $116,416 with UC. Thus, the average cost per patient was $21.40 for UC and $36.40 for TD. The incremental cost per patient was $15. The sensitivity analysis showed that the incremental cost per patient did not vary substantially in the alternative scenarios (the incremental cost varied from $10.50 to $13.85). measure of effectiveness The effectiveness evidence came from a clinical trial, which was appropriate for the study question. However, the study had been published already and limited information on the methods, study sample and results was provided. The use of a randomised trial ensures a high internal validity. However, it was not
1360%20-%20FinalAssessmentReport%20-accessible.docx